BackBio-Techne Overview

Bio-Techne Property, Plant & Equipment

Latest property, plant & equipment for TECH: $300M.

Get informed when a big investor buys or sells

+ Follow
PPE
$299.17M
↓ 6.25% YoYΔ $-19.95M vs prior year quarter

Peer trimmed avg / median

Loading

Bio-Techne PPE History

Loading

Bio-Techne vs. peers: PPE Comparison

Loading

Bio-Techne PPE Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bio-Techne (TECH) FAQ

As of the most recent data (June 2026), TECH shows a PP&E of $300M. That compares with $320M in the prior-year period — down 6.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TECH's PP&E is now $300M (was $320M) — a 6.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Techne is outperforming or lagging.

Tracking TECH's property, plant & equipment over time shows whether Bio-Techne is scaling, shrinking, or reshaping that part of the business. The current reading is $300M That compares with $320M in the prior-year period — down 6.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this property, plant & equipment page, Stockcircle has Bio-Techne's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PP&E (currently $300M) with ownership activity and broader fundamentals.

Bio-Techne's PP&E is $300M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.